146 related articles for article (PubMed ID: 1282894)
1. [Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].
Matsuura N; Mori H; Nagai H; Koda A
Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):495-501. PubMed ID: 1282894
[TBL] [Abstract][Full Text] [Related]
2. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
Boucher W; Kempuraj D; Cao J; Papaliodis D; Theoharides TC
J Urol; 2007 Mar; 177(3):1186-90. PubMed ID: 17296442
[TBL] [Abstract][Full Text] [Related]
3. [Antigenicity tests of suplatast tosilate (IPD-1151T)].
Kouchi Y; Ohuchida A; Maeda Y; Katayama S; Kurokawa M; Mizumoto T; Nakagawa M; Manabe H; Sugimoto S; Yoshida R
J Toxicol Sci; 1992 May; 17 Suppl 2():221-33. PubMed ID: 1321263
[TBL] [Abstract][Full Text] [Related]
4. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response.
Yanagihara Y; Kiniwa M; Ikizawa K; Yamaya H; Shida T; Matsuura N; Koda A
Jpn J Pharmacol; 1993 Jan; 61(1):23-30. PubMed ID: 8382322
[TBL] [Abstract][Full Text] [Related]
5. [Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice].
Matsuura N; Mori H; Nagai H; Koda A
Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):485-93. PubMed ID: 1336470
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of IPD-1151T (suplatast tosilate) on mast cell induction from normal mouse spleen cells].
Kouno S; Adachi M; Asano K; Okamoto K; Takahashi T
Arerugi; 1992 Oct; 41(10):1488-91. PubMed ID: 1336362
[TBL] [Abstract][Full Text] [Related]
7. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Adachi M
Arerugi; 1995 May; 44(5):556-61. PubMed ID: 7619009
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380
[TBL] [Abstract][Full Text] [Related]
9. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response.
Yanagihara Y; Kiniwa M; Ikizawa K; Shida T; Matsuura N; Koda A
Jpn J Pharmacol; 1993 Jan; 61(1):31-9. PubMed ID: 8382323
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes.
Konno S; Adachi M; Asano K; Gonogami Y; Ikeda K; Okamoto K; Takahashi T
Eur J Pharmacol; 1994 Jun; 259(1):15-20. PubMed ID: 7957588
[TBL] [Abstract][Full Text] [Related]
11. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
12. IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils.
Shichijo M; Shimizu Y; Hiramatsu K; Togawa M; Inagaki N; Takagi K; Nagai H
Jpn J Pharmacol; 1999 Apr; 79(4):501-4. PubMed ID: 10361893
[TBL] [Abstract][Full Text] [Related]
13. [Effect of KC-404 on allergic reactions types I-IV].
Nishino K; Hara S; Irikura T
Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
[TBL] [Abstract][Full Text] [Related]
14. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines.
Oda N; Minoguchi K; Yokoe T; Hashimoto T; Wada K; Miyamoto M; Tanaka A; Kohno Y; Adachi M
Life Sci; 1999; 65(8):763-70. PubMed ID: 10466742
[TBL] [Abstract][Full Text] [Related]
15. IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
Koda A; Yanagihara Y; Matsuura N
Agents Actions Suppl; 1991; 34():369-78. PubMed ID: 1665310
[TBL] [Abstract][Full Text] [Related]
16. [Mutagenicity tests of suplatast tosilate (IPD-1151T)].
Ohuchida A; Furukawa A; Sato S; Maeda Y; Kashihara A; Mizumoto T; Yoshida R
J Toxicol Sci; 1992 May; 17 Suppl 2():207-20. PubMed ID: 1321262
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N
BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
[TBL] [Abstract][Full Text] [Related]
18. [Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (1)--Fertility study in rats by oral administration].
Aso S; Sueta S; Kajiwara Y; Morita S; Horiwaki S; Yamakita O
J Toxicol Sci; 1992 May; 17 Suppl 2():141-54. PubMed ID: 1321258
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M
Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiallergic activity of dimethyl-2-(phenylcarbamoyl)ethylsulfonium p-toluenesulfonate derivatives.
Tada Y; Yamawaki I; Ueda S; Matsumoto H; Matsuura N; Yasumoto M; Koda A; Hori M
J Med Chem; 1998 Aug; 41(18):3330-6. PubMed ID: 9719585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
